Spero Therapeutics Stock Math Transform Inverse Tangent Over Price Movement
| SPRO Stock | USD 2.45 0.13 5.60% |
| Symbol |
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Spero Therapeutics Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Spero Therapeutics price patterns.
Spero Therapeutics Technical Analysis Modules
Most technical analysis of Spero Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Spero from various momentum indicators to cycle indicators. When you analyze Spero charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Spero Therapeutics Valuation Metrics
Spero Therapeutics is a micro-cap equity in Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care categories. Market multiples reflect competitive positioning. We evaluate Spero Therapeutics through the lens of long-term portfolio construction and diversification efficiency.
Methodology
Unless otherwise specified, financial data for Spero Therapeutics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Spero (USA Stocks:SPRO) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions Valuation estimates and intrinsic-value models use inputs from public financial disclosures and may not represent market consensus.
Assumptions
The dataset for Spero Therapeutics incorporates public filings and market reference sources and official institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Some inputs may not update instantaneously. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.Analyst Sources
Spero Therapeutics is covered by 1 analyst. Representative analyst firms may include Evercore ISI, Morgan Stanley, BMO Capital Markets, Oppenheimer & Co., Guggenheim Securities, among others. Updates may occur throughout the day.
Become your own money manager
Tracking Spero Therapeutics inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash position to determine if your portfolio needs rebalancing |
| All Next | Launch Module |
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Hedge Favorites Invested over 20 shares | |
 | Chemicals Makers Invested over 60 shares | |
 | Investor Favorites Invested over 200 shares | |
 | Macroaxis Index Invested few shares | |
 | Power Assets Invested over 200 shares | |
 | Macroaxis Picks Invested few shares | |
 | Advertising Invested few shares | |
 | Momentum Invested over 60 shares | |
 | FinTech Invested over 20 shares | |
 | Synthetics Invested over 70 shares | |
More Resources for Spero Stock Analysis
Reviewing Spero Therapeutics commonly begins with financial statements and performance trends. Financial ratios provide context for profitability, efficiency, and growth trends. Selected reports below provide context for Spero Stock:Review World Market Map to understand diversified portfolio construction. Refined allocation visibility enhances overall portfolio context. This suggests a position in Spero Therapeutics within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. Our How to Buy Spero Stock guide explains the steps to invest in Spero Therapeutics stock.Analysis related to Spero Therapeutics should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Quarterly Earnings Growth 0.753 | Earnings Share -0.79 | Revenue Per Share | Quarterly Revenue Growth -0.60 | Return On Assets |
Understanding Spero Therapeutics includes distinguishing between market value and book value, where book value reflects Spero accounting equity. Intrinsic value is an estimate of underlying worth, separate from trading price and book value. Market prices can move with sentiment and macro cycles, creating divergence from fundamentals. The valuation process compares these measures for perspective.
The concept of value for Spero Therapeutics differs from its quoted price, since each reflects a different lens. Reviewing financial results, valuation ratios, and competitive positioning helps frame the value discussion. Trading price represents the transaction level agreed by market participants.